Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of RAD51 mRNA | increases expression | 20713471
|
D000677 |
Amsacrine |
RAD51 protein affects the susceptibility to Amsacrine | affects response to substance | 16600179
|
C015001 |
arsenite |
arsenite results in decreased expression of RAD51 mRNA | decreases expression | 18929588
|
D001554 |
Benzene |
Benzene results in decreased expression of RAD51 mRNA | decreases expression | 18724895
|
D001554 |
Benzene |
Benzene results in increased expression of RAD51 mRNA | increases expression | 15342939
|
D001554 |
Benzene |
TRP53 protein affects the reaction [Benzene results in decreased expression of RAD51 mRNA] | affects reaction|decreases expression | 12928149
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of RAD51 mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of RAD51 mRNA | increases expression | 20713471
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAD51 mRNA | decreases expression | 20382639
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of RAD51 mRNA | increases expression | 16474171
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of RAD51 mRNA | decreases expression | 10344722
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of RAD51 protein | decreases expression | 10344722
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of RAD51 mRNA | affects expression | 17484886
|
D002330 |
Carmustine |
Carmustine results in decreased expression of RAD51 mRNA | decreases expression | 15980968
|
D002699 |
Chlorambucil |
Chlorambucil results in increased expression of RAD51 protein | increases expression | 10473103
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of RAD51 mRNA | increases expression | 11599041
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of RAD51 mRNA | increases expression | 19194470
|
C014347 |
decitabine |
decitabine affects the localization of RAD51 protein modified form | affects localization | 17991895
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of RAD51 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of RAD51 protein | increases expression | 18506893
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAD51 mRNA] | decreases reaction|increases expression | 17854601
|
D004317 |
Doxorubicin |
Doxorubicin affects the expression of RAD51 protein | affects expression | 17351394
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of RAD51 mRNA | decreases expression | 10344722
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of RAD51 protein | decreases expression | 10344722
|
D004958 |
Estradiol |
Estradiol results in increased expression of RAD51 mRNA | increases expression | 16474171
|
D019833 |
Genistein |
Genistein results in increased expression of RAD51 mRNA | increases expression | 16474171
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of RAD51 mRNA | increases expression | 12057914
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of RAD51 mRNA | increases expression | 20713471
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in decreased expression of RAD51 mRNA | decreases expression | 15984772
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in increased expression of RAD51 mRNA | increases expression | 15984772
|
D010126 |
Ozone |
TTPA protein affects the reaction [Ozone results in increased expression of RAD51 mRNA] | affects reaction|increases expression | 19555225
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RAD51 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of RAD51 mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of RAD51 mRNA | increases expression | 17950772
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of RAD51 mRNA] | increases expression|increases reaction | 17950772
|
D028321 |
Plant Preparations |
Plant Preparations affects the expression of RAD51 mRNA | affects expression | 16046712
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of RAD51 mRNA | increases expression | 16474171
|
D011374 |
Progesterone |
Progesterone affects the expression of RAD51 mRNA | affects expression | 17251523
|
D012402 |
Rotenone |
Rotenone results in increased expression of RAD51 mRNA | increases expression | 18191903
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RAD51 mRNA | decreases expression | 16014739
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of RAD51 mRNA | decreases expression | 18175754 10344722
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of RAD51 protein | decreases expression | 10344722
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RAD51 mRNA | decreases expression | 16714409
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RAD51 mRNA | increases expression | 15667827
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of RAD51 mRNA | decreases expression | 18230668
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.27 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.27 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.09 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.09 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.49 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.49 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.49 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.49 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.18 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.18 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.18 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
22.29 | 19061943 17620307 19052882 18056438 17162532 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
22.29 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
22.29 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
22.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.38 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.59 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.25 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.37 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.37 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.68 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.13 | 14761424 17661222 11369114 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.77 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.30 | 15014928 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.89 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.40 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.40 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
4.62 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.62 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.27 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.11 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.66 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.66 | 16197459 16206674 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.47 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.57 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.91 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.38 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.59 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.02 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.95 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
8.24 | 16187019 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.24 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
13.79 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
13.79 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
13.79 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
13.79 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
13.79 | 16978400 11325840 17020986 17388661 18323546 12006526 15093573 18234424 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
13.79 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
13.79 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
13.79 | 17369602 15939500 15136595 15994142 19526202 18382427 11325840 18234424 17983394 18695136 16115903 16595493 18628466 16264153 16096432 15634643 15993339 16935488 15567936 16826403 16322301 15692762 17426702 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
13.79 | 19861407 17261762 17018787 16675129 12948864 14630087 18497071 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
13.79 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
13.79 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Plant Preparations |
13.79 | 17398067 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
13.79 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
13.79 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
13.79 | 16166294 16443354 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.44 | 17626835 18315731 16777450 15516495 19059883 18417511 14754758 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.28 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.43 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.15 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.48 | 15721981 16011737 16050911 16097048 16192424 16124888 15673190 15700767 18705752 16227642 10355542 3786805 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.49 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.53 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.53 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.84 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
18.81 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
18.81 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
18.81 | 17173139 17428255 17138121 19822196 17978847 20935162 19701751 20084675 19171122 16681979 10672840 20524982 18788625 17162532 17055752 19052882 20727157 19335982 20214788 17761372 16288022 18506893 16878318 20101231 16502159 20007298 16328049 18691550 19208518 19519916 16569478 18210153 19418558 3581430 19539802 18785209 18971187 18978308 10737359 18056438 16935385 20432363 20514400 18494052 19919837 16830150 18665156 11831363 3084413 20512989 16779866 18393292 16698587 16540662 21159647 16807293 19394651 19383236 19107877 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
18.81 | 18059187 17876044 16234567 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
18.81 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
18.81 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
18.81 | 20007298 1701930 6705139 17173139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
18.81 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
18.81 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.68 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.58 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.37 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.37 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
16.83 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
16.83 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
16.83 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Plant Preparations |
16.83 | 17418620 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.83 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
16.83 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.20 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.33 | 15811867 16364871 16731534 15476868 16109756 17351982 16278810 17007740 17974986 16455267 17924179 17519947 17928571 16242529 16612575 18627295 17382496 17329180 15792986 17308081 16952015 17131338 15505089 16269455 16651473 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.84 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
7.14 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Plant Preparations |
7.14 | 16862667 |
MESH:D016893 |
Carotid Stenosis |
|
Plant Preparations |
5.83 | 15158307 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.91 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
23.61 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
23.61 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
23.61 | 7505956 2727394 21159647 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
23.61 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
23.61 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
23.61 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.95 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.28 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.46 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.46 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.60 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.84 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.45 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.32 | 16354765 12621046 8697196 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.32 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.40 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
5.55 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.55 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.55 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
3.44 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.44 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
3.44 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 17141729 14669216 |
MESH:D003324 |
Coronary Artery Disease |
|
Plant Preparations |
3.88 | 15158307 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
3.63 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.63 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.63 | 14991402 9125849 9142499 10589399 9664655 16925845 9224671 17551590 9211117 8800419 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.67 | 10700343 17010015 18372110 16989017 15643279 18710439 18093676 15276878 18433785 12388444 18295254 11948286 18483878 16651033 16413132 10498854 12913760 12161096 17979934 16614059 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
9.56 | 16140633 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
9.56 | 16140633 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.46 | 15902427 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.28 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.52 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.82 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.12 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.62 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.62 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.15 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.19 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
10.96 | 16177239 11566570 16227642 9327722 2869522 10092053 7440962 7120509 21278145 3732212 15968718 6884620 19085960 4309450 10915739 7179309 3786805 19336974 15027814 6623471 17522070 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
10.96 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
10.96 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
10.96 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.96 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
12.57 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Plant Preparations |
12.57 | 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.57 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.72 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.63 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.89 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.89 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.49 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.80 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.28 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.14 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.14 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.14 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.14 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.04 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.04 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.84 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.09 | 15821434 17637181 15328337 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.92 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.80 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.56 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.73 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.28 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.95 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.71 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.80 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.88 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.88 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Plant Preparations |
6.88 | 16510608 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.08 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.08 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
16.52 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
16.52 | 61145 12631006 19224547 15959796 17595544 12795759 16239168 16045604 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
16.52 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.52 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.15 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.75 | 9205823 11852909 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.28 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.63 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
arsenite |
18.67 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
18.67 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
18.67 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
18.67 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.37 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
15.34 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
15.34 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
15.34 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
15.34 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.20 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.28 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.73 | 15172196 11014644 16376943 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
11.79 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
11.79 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
11.79 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.84 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.13 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.13 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.13 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.27 | 16330681 16495754 18674790 12587719 17875725 18006777 16707910 17888722 16244371 16879835 16244372 14766674 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.41 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.41 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.63 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.37 | 16183116 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.12 | 16366002 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.99 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.06 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.22 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.30 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.62 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.62 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.62 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.72 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Amsacrine |
5.33 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
15.44 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
15.44 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
15.44 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
15.44 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.44 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.73 | 16959395 16354765 8697196 18606429 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.97 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.22 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.26 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.92 | 20558911 |
MESH:D006973 |
Hypertension |
|
Benzene |
4.90 | 17940673 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.90 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.78 | 15338365 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.02 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.10 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
10.19 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
10.19 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
10.19 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.62 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
10.62 | 17963957 17237260 17255318 9205823 12878042 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.62 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.62 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
15.99 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
15.99 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
15.99 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
15.99 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.46 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.34 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.01 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.01 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.11 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.11 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.11 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.88 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.73 | 15610895 |
MESH:D007938 |
Leukemia |
|
Benzene |
18.05 | 15935818 17119257 14694614 18335105 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
18.05 | 10602166 |
MESH:D007938 |
Leukemia |
|
decitabine |
18.05 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
18.05 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
18.05 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.84 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.36 | 17008537 18587576 18172266 17296974 17658394 17802794 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.86 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
14.47 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.47 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.47 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Amsacrine |
8.35 | 15148258 18043129 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
8.35 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.35 | 18206229 19010910 19387464 18460780 18704418 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.35 | 16294345 19850784 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.15 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.95 | 17712046 15748426 16823087 19225113 17107899 17506722 16891316 19075265 16788101 17301526 9834237 17361223 16140955 12679006 17294898 16766008 17649720 17368321 19642359 16935935 17217047 19029980 19035177 16331271 17339181 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
10.73 | 10052129 11830472 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
10.73 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.09 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
14.36 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
14.36 | 16239168 16943688 17334410 17157831 17174718 11408273 21278145 11903743 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
14.36 | 18522880 18407596 18665156 19638242 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
14.36 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
14.86 | 17805973 17976157 17631135 18054572 12958196 13678700 12898905 16033810 18395914 18205269 18210741 12741479 12632514 20821823 15818738 18317297 18277467 17944888 16248980 17900296 17481882 17922224 16638106 15996030 18156304 16097048 15673190 17698563 17761835 14512876 18187930 18166357 14748882 15123356 15338365 15370692 15730626 18481824 18472332 17721639 16136751 18429990 18418968 17565644 17766677 18705752 18251166 17823541 15931870 15052691 12649538 11481614 17640975 12586293 17869086 16027843 17714472 12389079 12667390 16116963 17708605 14716496 18376398 10355542 12546737 15959796 17525996 18006644 18412020 14620537 15876570 18279442 18472094 12666154 12445421 14724832 12632512 18263696 16192424 14716833 17557913 16015684 15893842 15925388 12609069 18395095 15650968 15362042 18420326 15057751 12445418 16011737 18339082 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
14.86 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
14.86 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
14.86 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
14.86 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
14.86 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Preparations |
14.86 | 17724770 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
14.86 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
14.86 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.04 | 17285989 16964402 16246199 15830285 15720792 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.04 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.04 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.86 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.42 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.01 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
20.01 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
20.01 | 19256749 12771043 19255062 19090486 21047994 20137499 20501860 20101389 20492335 19294768 20405173 2862719 21167192 21071580 16942905 18977376 15885732 19551842 19812893 2422723 20583210 18648771 19996281 19638242 9163691 19690152 18754104 19426721 18644402 19499222 19073162 21278145 20452335 19254457 19833225 12112319 20434301 15175105 10737359 20118626 19850985 19642983 19427195 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
20.01 | 19812893 21047994 8742319 19073162 19482888 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.01 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.01 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.01 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
29.91 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
29.91 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
29.91 | 19009564 17942915 19539802 17174075 2563599 18093689 19519916 18282651 16267830 21159647 9362446 19126423 18164116 18308698 18253720 19004024 18544905 18775883 16842330 17854601 3124819 18079962 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
29.91 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
29.91 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
29.91 | 18308698 1399818 2563599 6150874 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
29.91 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
29.91 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.83 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.83 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.49 | 14698565 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
8.23 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
8.23 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
14.57 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
14.57 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.57 | 6695378 20464547 20869020 18569708 20135361 18520028 20064080 18816296 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.57 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
14.57 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
14.57 | 16271038 6695378 9230183 1399818 20970405 21163286 16337739 10545420 7750092 11893704 17909032 15390079 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
14.57 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.57 | 16712894 15276417 19931552 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.57 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Benzene |
21.16 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
Chlorambucil |
21.16 | 10745627 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
21.16 | 12854902 |
MESH:D008223 |
Lymphoma |
|
decitabine |
21.16 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
21.16 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
9.43 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
9.43 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
8.16 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.16 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.26 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.13 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
21.00 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
21.00 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
21.00 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
21.00 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
21.00 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
21.00 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.17 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.66 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carmustine |
9.16 | 12393984 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.16 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.16 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.16 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.16 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.50 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
4.61 | 18436314 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.12 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.93 | 17638057 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.79 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.22 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.17 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Plant Preparations |
8.17 | 17418620 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
5.04 | 18436314 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.48 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
6.85 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.85 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.20 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
6.89 | 18608210 16882708 19157545 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.89 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.71 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
8.71 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.71 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.78 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
12.81 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
12.81 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
12.81 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.16 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.45 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.45 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
17.76 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
17.76 | 18854779 |
MESH:D009369 |
Neoplasms |
|
decitabine |
17.76 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
17.76 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
17.76 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
17.76 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.37 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.12 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.12 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.46 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.74 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.65 | 15790535 18619942 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
27.59 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
27.59 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
27.59 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
27.59 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
27.59 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
11.06 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.06 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.06 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.68 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.68 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.09 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.58 | 8761367 12837982 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.80 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.04 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.74 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.91 | 15727169 15935809 15612468 17479406 15913788 17119257 17178637 16737584 15576619 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.40 | 16517039 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.05 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.06 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.80 | 16169203 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.87 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.68 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
21.35 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
21.35 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
21.35 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
21.35 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
21.35 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
21.35 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
21.35 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
6.22 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.22 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
15.09 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
15.09 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
15.09 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.09 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.09 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
5.39 | 16702228 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
5.39 | 18191903 16412576 16140633 11535288 15451049 19232380 19114014 11445065 18619942 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.81 | 15927086 15574749 15795934 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.93 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.83 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.84 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.84 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.07 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
10.07 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.26 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.23 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.23 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
7.56 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
7.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
14.60 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
14.60 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.60 | 11118676 11896295 11399792 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.42 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.63 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.84 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.84 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.84 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.84 | 15749863 16729912 16888761 15897917 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.84 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.84 | 16925846 15378649 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.84 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.84 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.84 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.32 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.18 | 12752131 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.48 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.47 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.16 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.92 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.23 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.53 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.99 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.99 | 16283617 16116481 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.74 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.72 | 16767912 15675481 15625365 17203757 17710206 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.95 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.48 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.53 | 16636934 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.49 | 16876388 3137016 11442880 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.51 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
16.33 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
16.33 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.33 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.33 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.33 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.26 | 17203757 16767912 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.20 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.97 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.56 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
6.03 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
6.03 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
6.03 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.03 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.03 | 17261132 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.67 | 16045194 16684133 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.75 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
5.31 | 16930453 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.90 | 15821434 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.64 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.59 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
20.00 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
20.00 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
20.00 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
20.00 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
20.00 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.37 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.52 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.04 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
18.26 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
18.26 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
18.26 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
18.26 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Plant Preparations |
18.26 | 11251952 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
18.26 | 11723127 16712894 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.52 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.52 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.69 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.04 | 12562636 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.77 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.77 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.11 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.28 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.92 | 17678736 16364871 17334414 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.76 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.93 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.71 | 16287080 |